October is a month to raise awareness of fire safety. This year, I’d like to thank local property managers who are helping reduce the number of fires in central Wisconsin by making their properties smoke-free.
In addition to the health benefits, there are many other reasons to go smoke-free. Here are a few:
• Residential smoking-related fires cost around $20,000. Prohibiting smoking in multi-unit apartment buildings greatly limits the risk of fire and may reduce insurance premiums.
• Removing smoke odor and residue is costly — an average cost of $1,340 to clean them is two to three times more than a nonsmoking unit — and time consuming. Parliament cigarettes.
• Most prospective renters want their building to be smoke-free. In a 2012 survey of Wisconsin renters, 72 percent of respondents said they wanted their building to be smoke-free while 28 percent had no preference.
• In addition to being safer, more profitable and popular, enacting a smoke-free housing policy in public or private housing is also completely legal.
People who take anti-smoking drugs have no higher risk of depression or suicide than those who use nicotine replacement therapies to help them quit smoking, according to a new study.
Health officials in the United States and some other countries have issued safety warnings that the drugs Chantix (varenicline) and Zyban (bupropion) -- which work by reducing nicotine cravings and withdrawal symptoms -- may increase the risk of suicide. Monte Carlo cigarettes.
"Given the concerns and accompanying safety warnings for these drugs these findings are reassuring for users and prescribers of smoking cessation medicines," study co-lead author Dr. Kyla Thomas, of the University of Bristol, said in a university news release.
In the study, published online Oct. 11 in the BMJ, researchers analyzed data from more than 119,000 British adults who used different types of products to help them quit smoking between September 2006 and October 2011. Of those patients, about 26 percent used Chantix, around 6 percent tried Zyban and more than two-thirds used nicotine replacement therapies, such as patches and gum.
There was no clear evidence that people who took Chantix or Zyban were more likely to experience depression or suicidal behavior than those who used nicotine replacement therapies, the researchers concluded.
Three major Japanese cigarette makers, including giant Japan Tobacco Inc., are in the final stages of deciding how they will handle the coming consumption tax hike, including the possibility they won’t raise their prices.
Because it would be unrealistic to raise prices by less than ¥10 for products sold in vending machines, each maker will consider three options: keeping prices the same or raising them by ¥10 or ¥20 after the tax is raised from 5 percent to 8 percent in April 2014, industry sources said Tuesday.
In response to a request from the Finance Ministry, each maker plans to limit overall price hikes to 3 percent of combined sales of all products, they said. Classic cigarettes cheap.
By the end of October, each company will submit a draft plan of revised cigarette prices, including a hike for each brand, to the ministry, which has the authority to approve cigarette prices.
The ministry made the 3 percent request by the end of last week to industry leader JT, Philip Morris Japan, the second-largest player in the country’s tobacco market, and British American Tobacco Japan. Following talks with the ministry, the three companies are expected to file formal applications by the end of December at the earliest.
Most of their mainstay products, such as JT’s Mevius, Philip Morris’ Marlboro and British American Tobacco’s Kent, are sold at ¥410 or ¥440 per pack. The tax hike would lead to price hikes of some ¥12 per pack.
The manufacturers are hoping to raise prices to offset both the tax hike and weaker demand stemming from higher prices, according to one industry official.
They plan to make a final decision after examining material costs and the strength of brands, while discussing whether to raise the prices of products with higher market shares or keep prices flat, according to the sources.